Brooklyn FI LLC Purchases New Holdings in Agilent Technologies, Inc. (NYSE:A)

Brooklyn FI LLC acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 4th quarter, Holdings Channel reports. The firm acquired 42,496 shares of the medical research company’s stock, valued at approximately $5,822,000.

A number of other institutional investors also recently made changes to their positions in the business. CKW Financial Group raised its stake in shares of Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 100 shares in the last quarter. Global X Japan Co. Ltd. increased its holdings in Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after buying an additional 116 shares during the last quarter. RPg Family Wealth Advisory LLC acquired a new stake in Agilent Technologies during the third quarter valued at approximately $38,000. Hanson & Doremus Investment Management lifted its holdings in Agilent Technologies by 66.5% during the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after buying an additional 105 shares during the last quarter. Finally, OFI Invest Asset Management acquired a new position in shares of Agilent Technologies in the 4th quarter worth approximately $37,000.

Wall Street Analysts Forecast Growth

A has been the topic of several research analyst reports. Citigroup raised their price objective on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research note on Thursday, December 19th. StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Sanford C. Bernstein reduced their target price on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday, November 26th. Barclays upgraded shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $135.00 to $145.00 in a research note on Monday, February 10th. Finally, Bank of America reduced their price objective on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research report on Friday, December 13th. Seven research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $146.15.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the transaction, the vice president now directly owns 21,786 shares in the company, valued at approximately $2,657,456.28. This trade represents a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Agilent Technologies Price Performance

NYSE:A opened at $123.10 on Wednesday. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The business’s 50-day moving average price is $137.70 and its 200 day moving average price is $137.68. Agilent Technologies, Inc. has a 52-week low of $117.17 and a 52-week high of $155.35. The firm has a market cap of $35.09 billion, a P/E ratio of 28.30, a PEG ratio of 3.44 and a beta of 1.11.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The company had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.67 billion. As a group, sell-side analysts predict that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.81%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.